FDA Adverse Event Injury Summary report: N

UNKNOWN VLOC PRODUCT

MDR report key: 22185899 · Received June 11, 2025

Report

Report Number
1219930-2025-02516
Event Type
Injury
Date Received
June 11, 2025
Date of Event
May 1, 2025
Report Date
June 11, 2025
Manufacturer
COVIDIEN LP LLC NORTH HAVEN
Product Code
GAM
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
OH, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

EARLY EXPERIENCE WITH ENDOROBOTIC SUBMUCOSAL DISSECTION (ERSD) PATHOLOGIC AND SHORT-TERM OUTCOMES IN THE FIRST 28 PATIENTS / (B)(6) / (ANN SURG 2025;281:884¿889) / HTTPS://DOI.ORG/10.1097/SLA.0000000000006346. MEDTRONIC SUBMITS THIS REPORT TO COMPLY WITH FDA REGULATIONS 21 CFR PARTS 4 AND 803. MEDTRONIC HAS MADE REASONABLE EFFORTS TO PROVIDE AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE OF THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEE CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. ANY REQUIRED FIELDS THAT ARE UNPOPULATED ARE BLANK BECAUSE THE INFORMATION IS CURRENTLY UNKNOWN OR UNAVAILABLE. MEDTRONIC WILL SUBMIT A SUPPLEMENTAL REPORT IF ADDITIONAL RELEVANT INFORMATION BECOMES KNOWN.

Description of Event or Problem · 0

ACCORDING TO THE LITERATURE, A RETROSPECTIVE STUDY INCLUDING 28 CASES OF ENDOROBOTIC SUBMUCOSAL DISSECTION USING THE DA VINCI SINGLE PORT SYSTEM FOR COLORECTAL MUCOSAL NEOPLASMS WAS COMPLETED BETWEEN 2020 AND 2023. THE PROCEDURE WAS PERFORMED ROBOTICALLY UTILIZING A BARBED SUTURE TO CLOSE THE MUCOSAL DEFECT. COMPLICATIONS INCLUDED POSTOPERATIVE BLEEDING WITHOUT AN ACTIVE SOURCE, WHICH WAS OBSERVED DURING AN ENDOSCOPIC PROCEDURE AND REQUIRED A BLOOD TRANSFUSION. IT WAS ALSO NOTED THAT ONE OF THE INTERVENTIONS ALSO INCLUDED PROLONGED HOSPITALIZATION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
86581 UNKNOWN VLOC PRODUCT SUTURE, ABSORBABLE, SYNTHETIC, POLYGLYCOLIC AC GAM COVIDIEN LP LLC NORTH HAVEN UNKNOWN VLOC PRODUCT

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown Hospitalization| R